Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.041 | 0.8 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.8 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |